MY ACCOUNT | NEWSLETTER |

Fox tapeworm, a zoonotic parasite, found in Pacific Northwest

New university findings highlight potential implications for dogs, cancer, and veterinary practice.


In May, pathologists at Washington State University’s Washington Animal Disease Diagnostic Laboratory detected the tapeworm during a necropsy of a fox kit found on the WSU Pullman campus.

— A parasite commonly carried by foxes that can be passed to domestic dogs and cause severe illness in humans on rare occasions appears to have established itself in the Pacific Northwest.

Commonly known as the fox tapeworm, Echinococcus multilocularis is carried by foxes and coyotes and can spread to humans through contact with feces or feces-contaminated soil.

When humans are infected, they can develop a disease known as alveolar echinococcosis.

Symptoms may take years to appear and often do not emerge until significant liver damage has occurred.

The disease can mimic liver cancer and spread to other organs if left untreated.

While common in parts of Europe, Asia and northern North America, the parasite was not believed to be present in the Pacific Northwest until recently.

The diagnosis followed a study published in March in the journal PLOS Neglected Tropical Diseases that found the parasite is widespread in coyotes in the Puget Sound area.

Foxes and coyotes are common in and around Pullman and throughout the Pacific Northwest, increasing the potential for environmental contamination.

Experts recommend avoiding contact with wild animal feces, wearing gloves when cleaning areas where feces may be present and washing hands thoroughly afterward.

Pet owners should also prevent dogs from eating rodents or scavenging wildlife.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: Washington State University College of Veterinary Medicine

https://vetmed.wsu.edu/fox-tapeworm-a-zoonotic-parasite-found-in-pacific-northwest/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients

Like0
Dislike0

Hypersomatotropism without concurrent diabetes mellitus in cats 28 cases (2014-2024).

Like0
Dislike0

ACVIM-endorsed statement consensus statement and systematic review on guidelines for the diagnosis and treatment of chronic inflammatory enteropathy in dogs.

Like0
Dislike0

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses a descriptive clinical pilot stu

Like0
Dislike0

First total ear canal removal surgery performed on Ella the pig at Oregon State veterinary hospital

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top